| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.1M | +59.9% |
| Cost of Revenue | $2.9M | +77.0% |
| Gross Profit | $10.2M | +55.6% |
| R&D Expense | $60.0M | +122.6% |
| SG&A Expense | $47.6M | +871.1% |
| Operating Income | -$109.1M | -2123.9% |
| Interest Expense | $5.3M | +114.4% |
| Pre-tax Income | -$71.5M | -87.0% |
| Income Tax | $0 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.9M | +393.5% |
| Short-term Investments | $84.9M | — |
| Accounts Receivable | $6.2M | +304.1% |
| Current Assets | $154.5M | — |
| Total Assets | $203.4M | -41.2% |
| Current Liabilities | $21.8M | +413.4% |
| Total Liabilities | $53.2M | +12.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.7M | -6416.7% |
| Capital Expenditures | $22.7M | +224.4% |
| Investing Cash Flow | -$107.0M | +69.0% |
| Financing Cash Flow | $215.5M | -37.8% |
| Free Cash Flow | -$85.4M | -971.8% |
| — |
| Net Income | -$71.5M | -208.7% |
| EPS (Basic) | -$0.70 | +57.3% |
| EPS (Diluted) | -$0.70 | +57.3% |
| Stockholders' Equity |
| $150.2M |
| +423.2% |